FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a compound of formula (I) wherein A, D, R1, R2, R3, R4 and R5 are those as presented in cl.1 of the patent claim, as well as to its salt. What is also described is a method for preparing the compound of formula (I).
EFFECT: preparing new substituted chromanol derivatives exhibiting improved pharmacological activity with respect to cardiovascular diseases.
4 cl, 43 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
PURINE DERIVATIVES AS INHIBITORS OF TYROSINE PROTEINASE SYK | 2000 |
|
RU2248977C2 |
PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS | 2004 |
|
RU2481346C2 |
METHOD OF PRODUCING PYRAZOLES | 2015 |
|
RU2712192C2 |
SUBSTITUTED DERIVATIVES OF PURINE, METHODS FOR THEIR PREPARING AND PHARMACEUTICAL PREPARATION | 1997 |
|
RU2228335C2 |
PHOSPHONOXYQUINAZOLINE DERIVATIVES AND THEIR PHARMACEUTICAL APPLICATION | 2003 |
|
RU2357971C2 |
NEW ACYCLIC, SUBSTITUTED FUROPYRIMIDINE DERIVATIVES AND THEIR APPLICATION FOR TREATING CARDIOVASCULAR DISEASES | 2006 |
|
RU2454419C2 |
ALPHA-ARYL-N-ALKYLNITRONES, PHARMACEUTICAL COMPOSITIONS (VARIANTS), METHOD FOR INHIBITION OF NEURODEGENERATIVE DISEASES, METHOD FOR TREATMENT AND METHODS FOR PROPHYLAXIS (VARIANTS) | 1998 |
|
RU2225392C2 |
QUINAZOLINE DERIVATIVES | 2004 |
|
RU2356896C2 |
CYCLIC AMINO-DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHOD OF DISEASE PROPHYLAXIS | 1999 |
|
RU2203887C2 |
DERIVATIVES OF QUINOLINE, METHOD FOR THEIR PREPARING AND THEIR USING, MEDICINAL AGENT AND METHOD FOR INHIBITION OF TUMOR CELL PROLIFERATION | 2001 |
|
RU2265602C2 |
Authors
Dates
2012-08-27—Published
2007-03-07—Filed